Article
Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone.
Human pathology - 1 Aug 2014
Wu Peng Yan, Zhang Xu Dong, Zhu Jiang, Guo Xiang Yun, Wang Jin Fen
Abstract excerpt
Although diffuse large B-cell lymphoma (DLBCL) encompasses a biologically and clinically diverse set of diseases, increasing evidence has pointed to an important role of microRNAs (miRs) in the pathogenesis of DLBCL. We report here that low expression of miR-146b-5p and miR-320d is associated with poor prognosis of DLBCL patients treated with the standard cyclophosphamide, doxorubicin, vincristine, and prednisone...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.